The market reaction often makes me laugh, but that is what makes market opportunities. IMGN sales of Elahere blew away expectations as sales estimates for Q2 were in the low $44 million but came in at $77 million. The Chief Medical Officer announced she was leaving so it looks like that is what the market focused on. I remain bullish.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.